Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery

International Journal of Cardiology

Volumn 126, Issue 3, 2008, Pages 340-345

  Das, Rapti ^a   Balonan, Lino ^a   Ballard, Heather J ^b   Ho, Susan ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Hypoxia; Melatonin; Pulmonary artery

Indexed keywords

ACETYLCHOLINE; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; HYPOXIA; LUNG ARTERY; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ANOXIA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; MALE; MELATONIN; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; PULMONARY ARTERY; RANDOM ALLOCATION; RATS; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VASOCONSTRICTION; VASODILATION;

EID: 43149093341     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.04.030     Document Type: Article

References (38)

1. Zanaboni A., and Zanaboni-Muciaccia W. Experimental hypertension in pinealectomised rats. Life Sci 6 (1967) 2327
2. Sewerynek E. Melatonin and the cardiovascular system. Neuro Endocrinol Lett 23 Suppl. 1 (2002) 79-83 [Review]
3. Kawashima K., Miwa Y., Fujimoto K., et al. Antihypertensive action of melatonin in the spontaneously hypertensive rats. Clin Exp Hypertens 9 (1987) 1121-1131
4. Girouard H., Chulak C., Lejossec M., Lamontagne D., and De Champlain J. Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J Hypertens 19 (2001) 1369-1377
5. Holmes S.W., and Sugden D. The effect of melatonin on pinealectomy induced hypertension in the rat. Br J Pharmacol 56 (1976) 360-361
6. Harlow H.J. Influence of the pineal gland and melatonin on blood flow and evaporative water loss during heat stress in rats. J Pineal Res 4 2 (1987) 147-159
7. Evans B.K., Mason R., and Wilson V.G. Evidence for direct vasoconstrictor activity of melatonin in 'pressurized' segments of isolated caudal artery from juvenile rats. Arch Pharmacol 346 (1992) 362-365
8. Satake N., Oe H., Sawada T., and Shibata S. The mode of vasorelaxing action of melatonin in rabbit aorta. Gen Pharmacol 22 (1991) 219
9. Satake N., Sawada H., and Shibata S. The mode of vasorelaxing action of melatonin in rabbit aorta. Gen Pharmacol 22 (1991) 219-221
10. Doolen S., Duckles S.P., Geary G.G., and Krause D.N. Melatonin mediates vascular dilation via a distinct melatonin receptor sub-type. Soc Neurosci Abstr 23 (1997) 1517
11. Geary G.G., Krause D.N., and Duckles S.P. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am J Physiol (Heart Circ Physiol. 42) 273 (1997) H1530-Hl536
12. Viswanathan M., Scalbert E., Delagrange P., Guardiola-Lemaitre B., and Saavedra J. Melatonin receptors mediate contraction of a rat cerebral artery. Neuroreport 8 (1997) 3847-3849
13. Ting K.N., Blaylock N.A., Sugden D., et al. Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br J Pharmacol 127 (1999) 987-995
14. Cavallo A., Daniels S.R., Dolan L.M., Khoury J.C., and Bean J.A. Blood pressure response to melatonin in type 1 diabetes. Pediatr Diabetes 5 (2004) 26-31
15. Scheer F., Van Montfrans G.A., Van Someren E.J.W., Mairuhu G., and Buijs R.M. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43 (2004) 192-197
16. Satake N., Oe H., and Shibata S. Vasorelaxing action of melatonin in rat isolated aorta; possible endothelium dependent relaxation. Gen Pharmacol 22 (1991) 1127-1133
17. Brugger P., Marktl W., and Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 345 8962 (1995) 1408
18. Meyrick B., and Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am J Pathol 100 (1980) 151-178
19. Rounds S., and Hill N.S. Pulmonary hypertensive diseases. Chest 85 (1984) 397-405
20. Poncet L., Denory L., and Dalmaz Y. Effects of carotid sinus nerve transaction on changes in neuropeptide Y and indoleamines induced by long term hypoxia in rats. Eur J Physiol 437 (1998) 130-138
21. Coste O., Beaumont M., Batejat D., et al. Hypoxic depression of melatonin secretion after simulated long duration flights in man. J Pineal Res 37 1 (2000) 1-10
22. Poncet L., Péguignot J.-M., Cottet-Emard J.-M., et al. Altered daily rhythms of brain and pituitary indoleamines and neuropeptides in long-term hypoxic rats. Am J Physiol Regul Integr Comp Physiol 277 (1999) R66-R75
23. Pei J.M., Sun X., Guo H.T., et al. U50, 488H depresses pulmonary pressure in rats subjected to chronic hypoxia. J Cardiovasc Pharmacol 47 4 (2006) 594-598
24. Nomura N., Asano M., Saito T., et al. Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats. Ann Thorac Surg 76 1 (2003) 237-243
25. Monroe K.K., and Watts S.W. The vascular reactivity of melatonin. Gen Pharmacol 30 1 (1998) 31-35
26. Anwar M.M., Meki A.R., and Rahma H.H. Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators. Comp Biochem Physiol C Toxicol Pharmacol 130 3 (2001) 357-367
27. Lews M., and Flanders S. Mechanism of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction. Br J Pharmacol 126 (1999) 1408-1418
28. Geary G.G., Duckles S.P., and Krause D.N. Effect of melatonin in the rat tail artery: role of K+ channels and endothelial factors. Br J Pharmacol 123 8 (1998) 1533-1540
29. Dinh-Xuan A.T., Higenbottam T.W., Clelland C.A., et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 324 (1991) 1539-1547
30. Dakshinamurti S. Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 39 6 (2005) 492-503
31. Tulloh R.M., Hislop A.A., and Haworth S.G. Role of NO in recovery from neonatal hypoxic pulmonary hypertension. Thorax 54 (1999) 796-804
32. Dubocovich M.L. Melatonin receptor: are there multiple subtypes?. Trends Pharmacol Sci 16 (1995) 50-56
33. Ting N., Thambyraja A., Sugden D., Scalbert E., Dela P., and Wilson V.G. Pharmacological studies on the inhibitory action of melatonin and putative melatonin analogues on porcine vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 361 (2000) 327-333
34. Reiter R.J. Antioxidant actions of melatonin. Adv Pharmacol 38 (1997) 103-117
35. Wakatsuki A., and Okatani Y. Melatonin protects against the free radical-induced impairment of nitric oxide production in the human umbilical artery. J Pineal Res 28 (2000) 172-178
36. Masana M., Doolen S., Ersahin C., et al. MT2 melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 302 (2002) 1295-1302
37. Wu L., Wang R., and de Champlain J. Enhanced inhibition by melatonin of alpha-adrenoceptor-induced aortic contraction and inositol phosphate production in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 16 (1998) 339-347
38. Slanar O., Zemkova H., and Vanecek J. Melatonin inhibits GnRH-induced calciium mobilization and influx through voltage-regulated channels. Biol Signals 6 4-6 (1997) 284-290